Human placental mesenchymal stromal cells are ciliated and their ciliation is compromised in preeclampsia.
Cellular network formation
Human chorionic villi mesenchymal stromal cells
Motility
Placental organoids
Preeclampsia
Primary cilium
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
27 01 2022
27 01 2022
Historique:
received:
14
05
2021
accepted:
29
11
2021
entrez:
27
1
2022
pubmed:
28
1
2022
medline:
24
3
2022
Statut:
epublish
Résumé
The development of the human placenta is tightly coordinated by a multitude of placental cell types, including human chorionic villi mesenchymal stromal cells (hCV-MSCs). Defective hCV-MSCs have been reported in preeclampsia (PE), a gestational hypertensive disease characterized by maternal endothelial dysfunction and systemic inflammation. Our goal was to determine whether hCV-MSCs are ciliated and whether altered ciliation is responsible for defective hCV-MSCs in preeclamptic placentas, as the primary cilium is a hub for signal transduction, which is important for various cellular activities. In the present work, we collected placental tissues from different gestational stages and we isolated hCV-MSCs from 1st trimester, term control, and preeclamptic placentas. We studied their ciliation, functionality, and impact on trophoblastic cell lines and organoids formed from human trophoblast stem cells (hTSCs) and from the trophoblastic cell line JEG-3 with various cellular and molecular methods, including immunofluorescence staining, gene analysis, spheroid/organoid formation, motility, and cellular network formation assay. The statistical evaluation was performed using a Student's t test (two-tailed and paired or homoscedastic) or an unpaired Mann-Whitney U test (two-tailed). The results show that primary cilia appeared abundantly in normal hCV-MSCs, especially in the early development of the placenta. Compared to control hCV-MSCs, the primary cilia were truncated, and there were fewer ciliated hCV-MSCs derived from preeclamptic placentas with impaired hedgehog signaling. Primary cilia are necessary for hCV-MSCs' proper signal transduction, motility, homing, and differentiation, which are impaired in preeclamptic hCV-MSCs. Moreover, hCV-MSCs derived from preeclamptic placentas are significantly less capable of promoting growth and differentiation of placental organoids, as well as cellular network formation. These data suggest that the primary cilium is required for the functionality of hCV-MSCs and primary cilia are impaired in hCV-MSCs from preeclamptic placentas.
Sections du résumé
BACKGROUND
The development of the human placenta is tightly coordinated by a multitude of placental cell types, including human chorionic villi mesenchymal stromal cells (hCV-MSCs). Defective hCV-MSCs have been reported in preeclampsia (PE), a gestational hypertensive disease characterized by maternal endothelial dysfunction and systemic inflammation. Our goal was to determine whether hCV-MSCs are ciliated and whether altered ciliation is responsible for defective hCV-MSCs in preeclamptic placentas, as the primary cilium is a hub for signal transduction, which is important for various cellular activities.
METHODS
In the present work, we collected placental tissues from different gestational stages and we isolated hCV-MSCs from 1st trimester, term control, and preeclamptic placentas. We studied their ciliation, functionality, and impact on trophoblastic cell lines and organoids formed from human trophoblast stem cells (hTSCs) and from the trophoblastic cell line JEG-3 with various cellular and molecular methods, including immunofluorescence staining, gene analysis, spheroid/organoid formation, motility, and cellular network formation assay. The statistical evaluation was performed using a Student's t test (two-tailed and paired or homoscedastic) or an unpaired Mann-Whitney U test (two-tailed).
RESULTS
The results show that primary cilia appeared abundantly in normal hCV-MSCs, especially in the early development of the placenta. Compared to control hCV-MSCs, the primary cilia were truncated, and there were fewer ciliated hCV-MSCs derived from preeclamptic placentas with impaired hedgehog signaling. Primary cilia are necessary for hCV-MSCs' proper signal transduction, motility, homing, and differentiation, which are impaired in preeclamptic hCV-MSCs. Moreover, hCV-MSCs derived from preeclamptic placentas are significantly less capable of promoting growth and differentiation of placental organoids, as well as cellular network formation.
CONCLUSIONS
These data suggest that the primary cilium is required for the functionality of hCV-MSCs and primary cilia are impaired in hCV-MSCs from preeclamptic placentas.
Identifiants
pubmed: 35081949
doi: 10.1186/s12916-021-02203-1
pii: 10.1186/s12916-021-02203-1
pmc: PMC8793243
doi:
Substances chimiques
Hedgehog Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
35Informations de copyright
© 2022. The Author(s).
Références
Lancet. 2020 Feb 1;395(10221):335-336
pubmed: 32007162
Oxid Med Cell Longev. 2019 Jun 25;2019:9174521
pubmed: 31341539
Mol Aspects Med. 2007 Apr;28(2):192-209
pubmed: 17433431
Curr Protoc Stem Cell Biol. 2007 Jun;Chapter 1:Unit 1E.2
pubmed: 18785167
Reprod Biol Endocrinol. 2004 Aug 04;2:59
pubmed: 15294019
Stem Cell Res Ther. 2019 Aug 14;10(1):255
pubmed: 31412932
Cell Rep. 2017 May 30;19(9):1902-1916
pubmed: 28564607
Elife. 2019 Sep 04;8:
pubmed: 31482846
Stem Cells. 2016 Jun;34(6):1445-54
pubmed: 26866419
Placenta. 2021 Jan 15;104:243-246
pubmed: 33461068
Ann Thorac Surg. 2013 May;95(5):1827-33
pubmed: 23541427
Oncotarget. 2016 Dec 20;7(51):84271-84285
pubmed: 27713178
Methods Mol Biol. 2012;878:121-35
pubmed: 22674130
Cell Transplant. 2011;20(5):693-706
pubmed: 21176394
Hypertension. 2020 Nov;76(5):1491-1505
pubmed: 33026915
PLoS One. 2017 Feb 22;12(2):e0172642
pubmed: 28225815
Obes Rev. 2018 Oct;19(10):1317-1328
pubmed: 30015415
iScience. 2019 May 31;15:421-438
pubmed: 31121468
Cell Mol Life Sci. 2018 Oct;75(19):3507-3520
pubmed: 29992471
Sci Rep. 2015 Nov 20;5:16941
pubmed: 26585689
Hum Pathol. 2014 Jun;45(6):1234-42
pubmed: 24767250
PLoS One. 2013 Sep 19;8(9):e73337
pubmed: 24069188
Front Genet. 2019 Nov 08;10:1103
pubmed: 31781166
Cell Mol Life Sci. 2016 Jan;73(2):365-76
pubmed: 26496726
Nat Rev Genet. 2020 Jan;21(1):27-43
pubmed: 31534202
Hum Reprod. 2003 May;18(5):959-68
pubmed: 12721169
Sci Adv. 2018 Oct 31;4(10):eaau4788
pubmed: 30402542
J Womens Health (Larchmt). 2016 Mar;25(3):284-91
pubmed: 26779584
Placenta. 2021 May;108:122-133
pubmed: 33810901
Int J Mol Sci. 2017 Jul 20;18(7):
pubmed: 28726716
Oncol Lett. 2019 Nov;18(5):4377-4384
pubmed: 31611946
Stem Cell Reports. 2018 Feb 13;10(2):583-599
pubmed: 29396182
Trends Cell Biol. 2017 Feb;27(2):126-140
pubmed: 27634431
J Cell Physiol. 2012 Sep;227(9):3234-42
pubmed: 22105866
Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S115-22
pubmed: 26428489
Placenta. 2017 Nov;59:87-95
pubmed: 28411943
BMC Pregnancy Childbirth. 2014 Aug 15;14:278
pubmed: 25128406
Cell Adh Migr. 2014;8(2):94-7
pubmed: 24622731
Curr Biol. 2020 Nov 2;30(21):4299-4306.e5
pubmed: 32916106
Cell Mol Life Sci. 2020 Jul;77(14):2771-2794
pubmed: 31965214
Nat Protoc. 2007;2(3):481-5
pubmed: 17406610
Cell Cycle. 2009 Feb 1;8(3):460-72
pubmed: 19177004
Stem Cells. 2013 Sep;31(9):1980-91
pubmed: 23712682
Stem Cell Res Ther. 2019 Jan 11;10(1):19
pubmed: 30635045
Circ Res. 2019 Mar 29;124(7):1094-1112
pubmed: 30920918
Cell Biol Int. 2018 Jul;42(7):859-866
pubmed: 29465790
Nat Rev Nephrol. 2019 Apr;15(4):199-219
pubmed: 30733609
Cytokine. 2012 Dec;60(3):856-60
pubmed: 22921280
Placenta. 2013 Oct;34(10):913-23
pubmed: 23896030
Stem Cells. 2015 Feb;33(2):318-26
pubmed: 25267443
Acta Naturae. 2011 Oct;3(4):30-7
pubmed: 22649702
Exp Cell Res. 1993 Jun;206(2):204-11
pubmed: 7684692
Development. 2019 Nov 27;146(22):
pubmed: 31776138
Biol Reprod. 1998 Sep;59(3):643-54
pubmed: 9716565
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14071-6
pubmed: 12391318
Rev Obstet Gynecol. 2012;5(3-4):e137-43
pubmed: 23483768
Cell Mol Life Sci. 2019 Sep;76(18):3479-3496
pubmed: 31049600
Cells. 2019 Oct 21;8(10):
pubmed: 31640218
J Korean Med Sci. 2009 Aug;24(4):547-54
pubmed: 19654931
J Physiol. 2019 Jun;597(12):3069-3083
pubmed: 31026335
Oncotarget. 2015 Oct 27;6(33):34475-93
pubmed: 26439686
Nat Rev Mol Cell Biol. 2017 Sep;18(9):533-547
pubmed: 28698599
Cell Adh Migr. 2016 Mar 3;10(1-2):66-76
pubmed: 26745454
Br Med Bull. 2013;108:25-53
pubmed: 24152971
J Vis Exp. 2014 Sep 01;(91):e51312
pubmed: 25225985
Elife. 2016 Mar 22;5:
pubmed: 27003818
Sci Rep. 2018 Nov 2;8(1):16299
pubmed: 30389962
Semin Cell Dev Biol. 2021 Feb;110:89-103
pubmed: 32540122
Cell Rep. 2020 Nov 24;33(8):108419
pubmed: 33238118
Cell Death Dis. 2015 Feb 19;6:e1653
pubmed: 25695606
Lancet. 2010 Aug 21;376(9741):631-44
pubmed: 20598363
Carcinogenesis. 2003 Aug;24(8):1325-36
pubmed: 12807721
Nat Rev Nephrol. 2019 May;15(5):275-289
pubmed: 30792480
Stem Cells. 2007 Jul;25(7):1761-8
pubmed: 17395769
Obes Rev. 2018 Jul;19(7):888-904
pubmed: 29521029
Adv Sci (Weinh). 2018 Nov 16;6(1):1801138
pubmed: 30643718
PLoS One. 2013;8(3):e59403
pubmed: 23527185
Endocrinology. 2016 Sep;157(9):3529-39
pubmed: 27379371
Cell Stem Cell. 2018 Jan 4;22(1):50-63.e6
pubmed: 29249463
Int J Biochem Cell Biol. 2013 Nov;45(11):2456-66
pubmed: 23942228
Front Bioeng Biotechnol. 2020 Dec 17;8:610544
pubmed: 33392174
PLoS One. 2017 Aug 31;12(8):e0184182
pubmed: 28859160